Skip to main content
Envoy Medical, Inc. (COCH)
NASDAQ: COCH · IEX Real-Time Price · USD
2.210
-0.170 (-7.14%)
At close: Jul 2, 2024, 4:00 PM
2.270
+0.060 (2.71%)
After-hours: Jul 2, 2024, 7:59 PM EDT

Envoy Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
 Current202320222021
Market Capitalization
4335532517
Market Cap Growth
-85.65%-93.35%2.87%-
Enterprise Value
4432567540
PE Ratio
--1.18-33.43-48.47
PS Ratio
145.85112.022246.041669.15
PB Ratio
-10.34-20.09-14.71-11.51
P/FCF Ratio
-3.55-1.99-59.00-73.28
P/OCF Ratio
-3.59-2.01-60.46-74.60
EV/Sales Ratio
147.23100.452390.991741.27
EV/EBITDA Ratio
-3.37-1.07-35.76-62.74
EV/EBIT Ratio
-3.35-1.06-35.59-62.22
EV/FCF Ratio
-3.57-1.78-62.80-76.45
Debt / Equity Ratio
-0.72-0.32-0.95-0.52
Debt / EBITDA Ratio
-0.23-0.02-2.18-2.73
Debt / FCF Ratio
-0.25-0.03-3.83-3.32
Quick Ratio
0.740.670.090.87
Current Ratio
1.111.030.651.76
Asset Turnover
0.030.020.000.00
Interest Coverage
-638.92---
Return on Equity (ROE)
112.00%124.80%64.20%63.00%
Return on Assets (ROA)
-235.80%-154.60%-5.00%-3.30%
Return on Capital (ROIC)
947.89%1530.92%524.46%31.98%
Earnings Yield
-54.34%-84.49%-2.99%-2.06%
FCF Yield
-49.83%-50.31%-1.70%-1.36%
Buyback Yield / Dilution
-93.63%-24.00%92.73%-
Total Shareholder Return
-93.63%-24.00%92.73%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).